Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 9—September 2007
Research

Family Clustering of Viliuisk Encephalomyelitis in Traditional and New Geographic Regions

Vsevolod A. Vladimirtsev*, Raisa S. Nikitina*, Neil Renwick†, Anastasia A. Ivanova*, Al’bina P. Danilova*, Fyodor A. Platonov*, Vadim G. Krivoshapkin*, Catriona A. McLean‡, Colin L. Masters‡, D. Carleton Gajdusek§, and Lev G. Goldfarb¶Comments to Author 
Author affiliations: *Institute of Health–Sakha (Yakut) Republic, Yakutsk, Russian Federation; †Columbia University Medical Center, New York, New York, USA; ‡University of Melbourne, Parkville, Victoria, Australia; §Institut Alfred Fessard, Gif-sur-Yvette, France; ¶National Institutes of Health, Bethesda, Maryland, USA;

Main Article

Table 1

Clinical features of Viliuisk encephalomyelitis in affected members of 6 families*

Feature
Family 1
Family 2
Family 3
Family 4
Family 5
Family 6
1-1
1-2
1-3
2-1
2-2
3-1
3-2
4-1
4-2
4-3
5-1
5-2
6-1
6-2
6-3
Sex F F F F F F M M F F F F M F F
Age at onset, y 16 38 26 16 44 31 21 51 47 36 20 34 46 37 53
Febrile stage of illness
Duration, wk 7 11 2 2 10 ND 2 ND ND 4 ND 1 ND 6 26
Maximum temperature, oC 40.5 39 38 37.9 39.8 39.0 39.0 ND 38.5 38.8
Reduced level of
consciousness ++ +++ + +++ + ++ + +++
Generalized seizures ++ + +
Neck rigidity and Kernig sign + ++ + ++ + + +
Nausea, vomiting + ++ + ++ ++ +
Upper motor neuron pattern
of muscle weakness + + + +
Relapse of febrile illness + + + +
Outcome
a
d
a
a
d
a
a
a
a
a
a
a
a
a
d
Advanced disease
Cognitive decline ++ + ++ m.i. ++ ++ ++ ++ ++ ++ + ++
Apathy + + ++ + + + +
Dysarthria +++ ++ ++ ++ + ++ + ++ + +
Dysphagia + + + +
Brisk deep tendon reflexes ++ ++ ++ ++ ++ ++ + ++ + ++ + ++
Spastic tetraparaparesis +++ + ++ + ++ + ++ +++ + +
Increased muscle tone + + + + ++ + + ++ + +
Babinski sign + + + + + + + +
Spastic gait +++ ++ ++ + +++ + + + + + + +
Falls + ++ + + +
Sphincter dysfunction + ++ ++ +
Extrapyramidal rigidity + + ++ + ++ ++ + + + +
Obesity + + + +
Cachexia

+


+




++




+
Overall duration of illness 18 mo 11 wk A 48 mo 10 wk 17 y 24 mo 9 y 6 y 11 mo 11 y 23 mo 13 y 27
mo 26 wk

*ND, not documented; m.i., memory impairment; +, mild; ++, moderate; +++, strong; –, not expressed; d, died within acute phase; a, advanced disease developed; A, alive.

Main Article

Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external